TrialPsoriasis (Auckland, N.Z.)2025

Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients.

Stefanie Hölsken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.